Published by Iain Gilbert on 17th October 2019
(Sharecast News) - Regenerative medical devices group Tissue Regenix warned on Thursday that full-year revenues would be roughly 15-20% lower than anticipated after a delay in bringing increased manufacturing capabilities onstream.
URL: http://www.digitallook.com/dl/news/story/29723272/...